Cargando…

Pharmacotherapy for Cluster Headache

Cluster headache is characterised by attacks of excruciating unilateral headache or facial pain lasting 15 min to 3 h and is seen as one of the most intense forms of pain. Cluster headache attacks are accompanied by ipsilateral autonomic symptoms such as ptosis, miosis, redness or flushing of the fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandt, Roemer B., Doesborg, Patty G. G., Haan, Joost, Ferrari, Michel D., Fronczek, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018790/
https://www.ncbi.nlm.nih.gov/pubmed/31997136
http://dx.doi.org/10.1007/s40263-019-00696-2
_version_ 1783497394595299328
author Brandt, Roemer B.
Doesborg, Patty G. G.
Haan, Joost
Ferrari, Michel D.
Fronczek, Rolf
author_facet Brandt, Roemer B.
Doesborg, Patty G. G.
Haan, Joost
Ferrari, Michel D.
Fronczek, Rolf
author_sort Brandt, Roemer B.
collection PubMed
description Cluster headache is characterised by attacks of excruciating unilateral headache or facial pain lasting 15 min to 3 h and is seen as one of the most intense forms of pain. Cluster headache attacks are accompanied by ipsilateral autonomic symptoms such as ptosis, miosis, redness or flushing of the face, nasal congestion, rhinorrhoea, peri-orbital swelling and/or restlessness or agitation. Cluster headache treatment entails fast-acting abortive treatment, transitional treatment and preventive treatment. The primary goal of prophylactic and transitional treatment is to achieve attack freedom, although this is not always possible. Subcutaneous sumatriptan and high-flow oxygen are the most proven abortive treatments for cluster headache attacks, but other treatment options such as intranasal triptans may be effective. Verapamil and lithium are the preventive drugs of first choice and the most widely used in first-line preventive treatment. Given its possible cardiac side effects, electrocardiogram (ECG) is recommended before treating with verapamil. Liver and kidney functioning should be evaluated before and during treatment with lithium. If verapamil and lithium are ineffective, contraindicated or discontinued because of side effects, the second choice is topiramate. If all these drugs fail, other options with lower levels of evidence are available (e.g. melatonin, clomiphene, dihydroergotamine, pizotifen). However, since the evidence level is low, we also recommend considering one of several neuromodulatory options in patients with refractory chronic cluster headache. A new addition to the preventive treatment options in episodic cluster headache is galcanezumab, although the long-term effects remain unknown. Since effective preventive treatment can take several weeks to titrate, transitional treatment can be of great importance in the treatment of cluster headache. At present, greater occipital nerve injection is the most proven transitional treatment. Other options are high-dose prednisone or frovatriptan.
format Online
Article
Text
id pubmed-7018790
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-70187902020-02-28 Pharmacotherapy for Cluster Headache Brandt, Roemer B. Doesborg, Patty G. G. Haan, Joost Ferrari, Michel D. Fronczek, Rolf CNS Drugs Review Article Cluster headache is characterised by attacks of excruciating unilateral headache or facial pain lasting 15 min to 3 h and is seen as one of the most intense forms of pain. Cluster headache attacks are accompanied by ipsilateral autonomic symptoms such as ptosis, miosis, redness or flushing of the face, nasal congestion, rhinorrhoea, peri-orbital swelling and/or restlessness or agitation. Cluster headache treatment entails fast-acting abortive treatment, transitional treatment and preventive treatment. The primary goal of prophylactic and transitional treatment is to achieve attack freedom, although this is not always possible. Subcutaneous sumatriptan and high-flow oxygen are the most proven abortive treatments for cluster headache attacks, but other treatment options such as intranasal triptans may be effective. Verapamil and lithium are the preventive drugs of first choice and the most widely used in first-line preventive treatment. Given its possible cardiac side effects, electrocardiogram (ECG) is recommended before treating with verapamil. Liver and kidney functioning should be evaluated before and during treatment with lithium. If verapamil and lithium are ineffective, contraindicated or discontinued because of side effects, the second choice is topiramate. If all these drugs fail, other options with lower levels of evidence are available (e.g. melatonin, clomiphene, dihydroergotamine, pizotifen). However, since the evidence level is low, we also recommend considering one of several neuromodulatory options in patients with refractory chronic cluster headache. A new addition to the preventive treatment options in episodic cluster headache is galcanezumab, although the long-term effects remain unknown. Since effective preventive treatment can take several weeks to titrate, transitional treatment can be of great importance in the treatment of cluster headache. At present, greater occipital nerve injection is the most proven transitional treatment. Other options are high-dose prednisone or frovatriptan. Springer International Publishing 2020-01-29 2020 /pmc/articles/PMC7018790/ /pubmed/31997136 http://dx.doi.org/10.1007/s40263-019-00696-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Review Article
Brandt, Roemer B.
Doesborg, Patty G. G.
Haan, Joost
Ferrari, Michel D.
Fronczek, Rolf
Pharmacotherapy for Cluster Headache
title Pharmacotherapy for Cluster Headache
title_full Pharmacotherapy for Cluster Headache
title_fullStr Pharmacotherapy for Cluster Headache
title_full_unstemmed Pharmacotherapy for Cluster Headache
title_short Pharmacotherapy for Cluster Headache
title_sort pharmacotherapy for cluster headache
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018790/
https://www.ncbi.nlm.nih.gov/pubmed/31997136
http://dx.doi.org/10.1007/s40263-019-00696-2
work_keys_str_mv AT brandtroemerb pharmacotherapyforclusterheadache
AT doesborgpattygg pharmacotherapyforclusterheadache
AT haanjoost pharmacotherapyforclusterheadache
AT ferrarimicheld pharmacotherapyforclusterheadache
AT fronczekrolf pharmacotherapyforclusterheadache